abstract |
The invention relates to compounds of structural formula (I): (see formula I) or a pharmaceutically acceptable salt, solvate, clathrate, and prodrug thereof, wherein R a, R b, and R2 are defined herein. These compounds inhibit tubulin polymerization and/or target vasculature and are useful for treating proliferative disorders, such as cancer. |